Previous 10 | Next 10 |
Latest System Designed for Single Session Arterial Thrombus Removal Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Indigo ® System Lightning ™ 7. Lightning 7 exp...
RADNOR, Pa., March 15, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Penumbra, Inc. (NYSE: PEN) (ȁ...
BOSTON, MA / ACCESSWIRE / March 9, 2021 / Nationally-recognized securities law firm Block & Leviton LLP ( www.blockleviton.com ) announces that a lawsuit for violation of the federal securities laws has been filed against Penumbra, Inc. (NYSE:PEN) and certain of its executives. After th...
RADNOR, PA / ACCESSWIRE / March 4, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc. ("Penumbra") on behalf of those who purchased or acquired Penumbra (NYSE:PEN) common stock between A...
Penumbra has been impacted by the pandemic and the recall of its leading-edge neurovascular aspiration catheter, but those only look like bumps in the growth story. With the JET 7 Flex Xtra off the market, management is seeing robust demand for older models and is currently capacity-c...
Penumbra, Inc. (PEN) Q3 2020 Results Earnings Conference Call February 23, 2021, 08:00 AM ET Company Participants Jee Hamlyn-Harris - Investor Relations Adam Elsesser - President, Chairman and Chief Executive Officer Maggie Yuen - Chief Financial Officer Jason Mills - Executive Vice President...
Image source: The Motley Fool. Penumbra Inc (NYSE: PEN) Q4 2020 Earnings Call Feb 23, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Penumbra Inc (PEN) Q4 2020 Earnings Call Transcript
Penumbra (PEN): Q4 Non-GAAP EPS of $0.42 beats by $0.48; GAAP EPS of $0.10 beats by $0.17.Revenue of $166.9M (+14.9% Y/Y) beats by $7.21M.Full Year 2021 Financial OutlookPenumbra projects total revenue for 2021 to be in the range of $675M to $685M, which represents growth of 20% to 22% over 2...
Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire ALAMEDA, Calif. , Feb. 23, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) , a global healthcare company focused on innovative therapies, today reported financial...
NEW YORK, NY / ACCESSWIRE / February 19, 2021 / Nationally ranked litigation firm Labaton Sucharow announces investigation of Penumbra, Inc. ("Penumbra" or the "Company") (NYSE:PEN) and encourages investors with losses to contact the firm. Penumbra, Inc. designs, develops, manufactures, and ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...